for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

ビジネス

AstraZeneca shares dip after $39 bln Alexion deal

AstraZeneca shares fell on Monday, as investors moved to price in the British drugmaker's $39 billion deal for U.S. biotech firm Alexion Pharmaceuticals, the company's largest ever takeover and one of this year's biggest mergers globally. Ciara Lee reports

最新のビデオ
エンタテインメント
世界のこぼれ話
スポーツ
テクノロジー

ビジネス

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up